Your browser doesn't support javascript.
loading
MG53 marks poor beta cell performance and predicts onset of type 2 diabetes in subjects with different degrees of glucose tolerance.
Bianchi, Cristina; Raggi, Francesco; Rossi, Chiara; Frontoni, Simona; Bonadonna, Riccardo C; Del Prato, Stefano; Solini, Anna.
Afiliação
  • Bianchi C; Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Raggi F; Department of Surgical, Medical, Molecular and Critical Area Pathology, University of Pisa, Via Roma 67, Pisa 56126, Italy.
  • Rossi C; Department of Surgical, Medical, Molecular and Critical Area Pathology, University of Pisa, Via Roma 67, Pisa 56126, Italy.
  • Frontoni S; Tor Vergata University, Rome, Italy.
  • Bonadonna RC; Department of Medicine and Surgery, University of Parma, Italy; Azienda Ospedaliero-Universitaria of Parma, Italy.
  • Del Prato S; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Solini A; Department of Surgical, Medical, Molecular and Critical Area Pathology, University of Pisa, Via Roma 67, Pisa 56126, Italy. Electronic address: anna.solini@med.unipi.it.
Diabetes Metab ; 48(2): 101292, 2022 Mar.
Article em En | MEDLINE | ID: mdl-34678488

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Intolerância à Glucose / Diabetes Mellitus Tipo 2 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Intolerância à Glucose / Diabetes Mellitus Tipo 2 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article